TVRNA - Overview: Trichomonas vaginalis, Nucleic Acid Amplification, Varies
Detecting Trichomonas vaginalis in urine, cervical/endocervical or vaginal specimen types
HBVQN - Overview: Hepatitis B Virus (HBV) DNA Detection and Quantification by Real-Time PCR, Serum
Detection and quantification of hepatitis B virus (HBV) DNA in serum of patients with chronic HBV infection (ie, hepatitis B surface antigen-positive) Monitoring disease progression in chronic HBV infection Monitoring response to anti-HBV...
ABOPC - Overview: Arbovirus Antibody Panel, IgG and IgM, Spinal Fluid
Aiding in the diagnosis of arboviral encephalitis (California [LaCrosse], St Louis, Eastern equine, and Western equine encephalitis)
Monitoring response to therapy in patients with chronic myeloid leukemia who are known to have the e13/a2 or e14/a2 BCR/ABL1 fusion transcript forms
PTH2 - Overview: Parathyroid Hormone, Serum
Diagnosis and differential diagnosis of hypercalcemia Diagnosis of primary, secondary, and tertiary hyperparathyroidism Diagnosis of hypoparathyroidism Monitoring kidney failure patients for possible renal osteodystrophy
CMVPV - Overview: Cytomegalovirus (CMV) Molecular Detection, PCR, Varies
Rapid qualitative detection of cytomegalovirus (CMV) DNA This test is not intended for the monitoring of CMV disease progression.
Detecting Chlamydia trachomatis and Neisseria gonorrhoeae using a throat swab collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications. This test is not useful for the detection of...
Detecting Chlamydia trachomatis and Neisseria gonorrhoeae using self-collected vaginal swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications. This test is not useful for the...
Detecting Chlamydia trachomatis and Neisseria gonorrhoeae in non-US Food and Drug Administration-approved specimen types This test is not intended for use in medico-legal applications. This test is not useful for the detection of...
DPYDZ - Overview: Dihydropyrimidine Dehydrogenase, DPYD Full Gene Sequencing, Varies
Identifying individuals at increased risk of toxicity when considering 5-fluorouracil and capecitabine chemotherapy treatment Identifying common and rare variants associated with decreased or absent dihydropyrimidine dehydrogenase (DPD)...
FGFR2 - Overview: FGFR2 (10q26.1) Rearrangement, FISH, Tissue
Providing prognostic information and guiding treatment for patients with cholangiocarcinomas and other tumor types including bladder, thyroid, oral cavity, and brain
Diagnosis of COVID-19 illness due to SARS-CoV-2
Detecting Chlamydia trachomatis and Neisseria gonorrhoeae using rectal swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications. This test is not useful for the detection of...
5BETH - Overview: Factor V Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against coagulation factor V
RCTUR - Overview: Creatinine, Random, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine Normalization of urinary analytes by creatinine concentration to account for the variation in urinary concentrations between...
METR1 - Overview: Cytochrome b5 Reductase Enzyme Activity, Blood
Evaluation of patients with cyanosis Confirming cases of suspected cytochrome b5 reductase (methemoglobin reductase) deficiency Functional studies in families with cytochrome b5 reductase deficiency
CRETR - Overview: Creatinine, Random, Urine
Normalization of urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
HAEV0 - Overview: Hemolytic Anemia Summary Interpretation
Incorporating and summarizing subsequent results into an overall interpretation for the HAEV1 / Hemolytic Anemia Evaluation, Blood
GBETH - Overview: General Factor Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against a specific coagulation factor
ACT - Overview: Actinomyces Culture, Varies
Diagnosing anaerobic Actinomyces involved in infections
CRTFR - Overview: Creatinine, Random, Urine
Normalizing urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
CNSA - Overview: Central Nervous System Consultation, Autopsy, Varies
Evaluation of congenital neurological disease Evaluation of neurodegenerative disease Evaluation of cases with a complex neurological or neurosurgical history Evaluation of sudden unexplained death This test is not intended for...
OSM24 - Overview: Osmolality, 24 Hour, Urine
Assessing the concentrating and diluting ability of the kidney using a 24-hour urine collection
CRT2F - Overview: Creatinine, 24 Hour, Urine
Normalizing urinary analytes to account for the variation in urinary concentration
FVAG - Overview: Fungal Culture, Vaginal
Monitoring therapy for vulvovaginitis Managing chronic recurring disease Determining the etiology of infectious vaginitis when other tests have been uninformative
UHSD2 - Overview: Hemosiderin, Random, Urine
Detecting hemosiderinuria, secondary to excess hemolysis, as in incompatible blood transfusions, severe acute hemolytic anemia, or hemochromatosis for external patients.
8INHE - Overview: Factor VIII Inhibitor Evaluation, Plasma
Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating...
PSGN - Overview: Plasminogen Activity, Plasma
Evaluating patients with ligneous conjunctivitis (strong association with homozygous plasminogen deficiency) Evaluating fibrinolysis, in combination with other components of the fibrinolytic system (fibrinogen, tissue...
HAEVI - Overview: Hemolytic Anemia Interpretation
Interpretation of the results for the evaluation of hemolytic anemia Evaluation of lifelong or inherited hemolytic anemias, including red cell membrane disorders, unstable or abnormal hemoglobin variants, and red cell enzyme disorders
CRT24 - Overview: Creatinine, 24 Hour, Urine
Urinary creatinine, in conjunction with serum creatinine, is used to calculate the creatinine clearance, a measure of renal function Normalizing urinary analytes to account for the variation in urinary concentration
CTU - Overview: Creatinine, 24 Hour, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine
UNHB - Overview: Hemoglobin Stability, Blood
Work-up of congenital hemolytic anemias
CBL - Overview: Blastomyces Antibody Immunodiffusion, Spinal Fluid
Detection of antibodies in spinal fluid specimens from patients with blastomycosis
CFRCS - Overview: Bacterial Culture, Cystic Fibrosis with Antimicrobial Susceptibilities, Varies
Detecting disease-causing aerobic bacteria in specimens from patients with cystic fibrosis Determining the in vitro antimicrobial susceptibility of potentially pathogenic aerobic bacteria, if appropriate
10_IS - Overview: Factor X Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor X
F7_IS - Overview: Factor VII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VII
11_IS - Overview: Factor XI Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor XI
FRUCT - Overview: Fructosamine, Serum
Monitoring intermediate (1-3 weeks) glycemic control Monitoring glycemic control in patients with shortened red blood cell survival
SDEX - Overview: Sickle Solubility, Blood
Screening for presence or absence of hemoglobin (Hb) S (sickle cell disease)
FMBNY - Overview: Fetomaternal Bleed, New York, Blood
Determining the volume of fetal-to-maternal hemorrhage for the purposes of recommending an increased dose of the Rh immune globulin This test is used only for specimens collected in New York state.
GALP - Overview: Galactose, Quantitative, Plasma
Screening for galactosemia
FMB - Overview: Fetomaternal Bleed, Flow Cytometry, Blood
Determining the volume of fetal-to-maternal hemorrhage for the purposes of recommending an increased dose of the Rh immune globulin
PD2T - Overview: Pompe Disease Second-Tier Newborn Screening, Blood Spot
Second-tier testing of newborns with an abnormal primary screening result for Pompe disease (decreased acid alpha-glucosidase enzyme activity) Follow-up testing for evaluation of an abnormal newborn screening result for Pompe disease
Detection of acute hepatitis C virus (HCV) infection before the appearance of HCV antibodies in serum (ie, <2 months from exposure) Detection and confirmation of chronic HCV infection Quantification of HCV RNA in serum of patients with...
RETF - Overview: Lung Cancer, RET (10q11) Rearrangement, FISH, Tissue
Identifying RET gene rearrangements in patients with late-stage, lung adenocarcinomas that are negative for epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements Fluorescence in situ hybridization (FISH)...
LMPP - Overview: Lipoprotein Metabolism Profile, Serum
Diagnosing dyslipoproteinemia Quantifying cholesterol and triglycerides in very-low-density lipoprotein, low-density lipoprotein (LDL), high-density lipoproteins (HDL), and chylomicrons Identifying lipoprotein-X Classifying...
ALKT - Overview: ALK Mutation Analysis, Next-Generation Sequencing, Tumor
Identifying mutations within the ALK gene that predict resistance to ALK-inhibitors
Evaluating patients with chronic myelogenous leukemia and Philadelphia chromosome positive B-cell acute lymphoblastic leukemia receiving tyrosine kinase inhibitor (TKI) therapy, who are apparently failing treatment Preferred initial test...
Detecting Mycoplasma genitalium in cases of suspected infection This test is not intended for use in medico-legal applications.
DRVI2 - Overview: Dilute Russell's Viper Venom Time (DRVVT) Mix Ratio, Plasma
Detecting the presence or helping to exclude the presence of lupus anticoagulants (LA) Identifying LA that do not prolong the activated partial thromboplastin time (APTT) Evaluating unexplained prolongation of the APTT or prothrombin...
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by...
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
the American Academy of Neurology Annual Meeting 2023 - Insights
Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023....
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
the American Academy of Neurology Annual Meeting 2023 - Insights
the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023....